Angiogenic and lymphangiogenic cascades in the tumor microenvironment

Frontiers in Bioscience - Scholar

Volumn 3 S, Issue 1, 2011, Pages 216-225

  Onimaru, Mitsuho ^a   Yonemitsu, Yoshikazu ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Cytokine Networks; Review; Tumor Angiogenesis; Tumor Lymphangiogenesis; Tumor Microenvironment

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET-DERIVED GROWTH FACTOR A; VASCULOTROPIN RECEPTOR 2; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; AUTOCRINE EFFECT; ENDOTHELIUM CELL; HUMAN; IMMUNOTHERAPY; LYMPHANGIOGENESIS; PARACRINE SIGNALING; PROTEIN EXPRESSION; SENSORIMOTOR FUNCTION; STROMA CELL; THERAPY EFFECT; TUMOR CELL; TUMOR MICROENVIRONMENT; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VASCULARIZATION;

AUTOCRINE COMMUNICATION; FIBROBLAST GROWTH FACTOR 2; HUMANS; LYMPHANGIOGENESIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PARACRINE COMMUNICATION; PLATELET-DERIVED GROWTH FACTOR; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; TUMOR MICROENVIRONMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 79955943755     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s146     Document Type: Article

References (51)

1. P. Carmeliet, R. K. Jain RK: Angiogenesis in cancer and other diseases. Nature, 407, 249-257 (2000)
2. J. Folkman: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med, 1, 27-31 (1995)
3. K. Alitalo, T. Tammela, T. V. Petrova: Lymphangiogenesis in development and human disease. Nature, 438, 946-953 (2005) (Pubitemid 43093960)
4. J. Folkman: Tumor angiogenesis: therapeutic implications. N Engl J Med, 285, 1182-1186 (1971)
5. J. Folkman: Role of angiogenesis in tumor growth and metastasis. Semin Oncol, 29, 15-18 (2002)
6. N. Ferrara, K. Alitalo: Clinical applications of angiogenic growth factors and their inhibitors. Nat Med, 5, 1359-1364 (1999)
7. P. Carmeliet: Angiogenesis in health and disease. Nat Med, 9, 653-660 (2003) (Pubitemid 36749213)
8. S. J. Mandriota, L. Jussila, M. Jeltsch, A. Compagni, D. Baetens, R. Prevo, S. Banerji, J. Huarte, R. Montesano, D. G. Jackson, L. Orci, K. Alitalo, G. Christofori, M. S. Pepper: Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J, 20, 672-682 (2001) (Pubitemid 32167632)
9. A. C. Schinzel, W. C. Hahn: Oncogenic transformation and experimental models of human cancer. Front Biosci, 13, 71-84 (2008) (Pubitemid 351594764)
10. N. Ferrara, H. P. Gerber, J. LeCouter: The biology of VEGF and its receptors. Nat Med, 9, 669-676 (2003) (Pubitemid 36749215)
11. M. Onimaru, Y. Yonemitsu, T. Fujii, M. Tanii, T. Nakano, K. Nakagawa, R. Kohno, M. Hasegawa, S. Nishikawa, K. Sueishi: VEGF-C regulates lymphangiogenesis and c apillary stability by regulation of PDGF-B. Am J Physiol Heart Circ Physiol, 297, H1685-1696 (2009)
12. J. Folkman: Therapeutic angiogenesis in ischemic limbs. Circulation, 97, 1108-1110 (1998) (Pubitemid 28152881)
13. D. L. Staudacher, M. Preis, B. S. Lewis, P. M. Grossman, M. Y. Flugelman: Cellular and molecular therapeutic modalities for arterial obstructive syndromes. Pharmacol Ther, 109, 263-273 ( 2006) (Pubitemid 41740826)
14. H. Kamihata, H. Matsubara, T. Nishiue, S. Fujiyama, Y. Tsutsumi, R. Ozono, H. Masaki, Y. Mori, O. Iba, E. Tateishi, A. Kosaki, S. Shintani, T. Murohara, T. Imaizumi, T. Iwasaka: Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation, 104, 1046-1052 (2001) (Pubitemid 32803883)
15. T. Asahara, T. Murohara, A. Sullivan, M. Silver, R. van der Zee, T. Li, B. Witzenbichler, G. Schatteman, J. M. Isner: Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275, 964-967 (1997). (Pubitemid 27087709)
16. P. Carmeliet: VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nat Med, 6, 1102-1103 (2000)
17. E. R. Schwarz, M. T. Speakman, M, Patterson, S. S. Hale, J. M. Isner, L. H. Kedes, R. A. Kloner: Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat - angiogenesis and angioma formation. J Am Coll Cardiol, 35, 1323-1330 (2000) (Pubitemid 30206908)
18. R. J. Lee, M. L. Springer, W. E. Blanco-Bose, R. Shaw, P. C. Ursell, H. M. Blau: VEGF Gene delivery to myoca rdium: deleterious effects of unregulated expression. Circulation, 102, 898-901 (2000)
19. G. Thurston, J. S. Rudge, E. Ioffe, H. Zhou, L. Ross, S. D. Croll, N. Glazer, J. Holash, D. M. McDonald, G. D. Yancopoulos: Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med, 6, 460-463 (2000) (Pubitemid 30208166)
20. C. R. Ozawa, A. Banfi, N. L. Glazer, G. Thurston, M. L. Springer, P. E. Kraft, D. M. McDonald, H. M. Blau: Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aber rant angiogenesis. J Clin Invest, 113, 516-527 (2004) (Pubitemid 38542501)
21. A. Armulik, A. Abramsson, C. Betsholtz. Endothelial/pericyte interactions. Circ Res, 16, 512-523 (2005) (Pubitemid 41361741)
22. I. Masaki, Y. Yonemitsu, A. Yamashita, S. Sata, M. Tanii, K. Komori, K. Nakagawa, X. Hou, Y. Nagai, M. Hasegawa, K. Sugimachi, K. Sueishi: Angiogenic gene therapy for experimental critical limb ischemia; Acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not fibroblast growth factor-2. Circ Res, 90, 966-973 (2002) (Pubitemid 34633862)
23. M. Onimaru, Y. Yonemitsu, M. Tanii, K. Nakagawa, I. Masaki, S. Okano, H. Ishibashi, K. Shirasuna, M. Hasegawa, K. Sueishi: Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated down regulation in ischemic limb. Circ Res, 91, 923-930 (2002) (Pubitemid 35373592)
24. M. Matsuura, M. Onimaru, Y. Yonemitsu, H. Suzuki, T. Nakano, H. Ishibashi, K. Shirasuna, K. Sueishi: Autocrine loop between vascular endothe lial growth factor (VEGF)-C and VEGF receptor-3 positively regulates tumor-associated lymphangiogenesis in oral squamoid cancer cells. Am J Pathol, 175, 1709-1721 (2009)
25. Y. Ren, B. Cao, S. Law, Y. Xie, P. Y. Lee, L. Cheung, Y. Chen, X. Huang, H. M. Chan, P. Zhao, J. Luk, G. Vande Woude, J. Wong: Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas. Clin Cancer Res, 11, 6190-6197 (2005) (Pubitemid 41262947)
26. D. Tulasne, R. Paumelle, C. Leroy, S. Reveneau, B. Vandenbunder, V. Fafeur: Involvement of Ras-ERK sig naling in multiple biological responses to HGF/SF. Ann NY Acad Sci, 973, 105-108 (2002) (Pubitemid 36124986)
27. Y. Tang, D. Zhang, L. Fallavollita, P. Brodt: Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor. Cancer Res, 63, 1166-1171 (2003) (Pubitemid 36348689)
28. J. Li, E. Wang, F. Rinaldo, K. Datta: Upregulation of VEGF-C by androgen depletion: the involvement of IGF-IRFOXO pathway. Oncogene, 24, 5510-5520 (2005) (Pubitemid 43080094)
29. S. Dias, K. Hattori, Z. Zhu, B. Heissig, M. Choy, W. Lane, Y. Wu, A. Chadburn, E. Hyjek, M. Gi ll, D. J. Hicklin, L. Witte, M. A. Moore, S. Rafii: Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest, 106, 511-521 (2000) (Pubitemid 30666384)
30. R. Masood, J. Cai, T. Zheng, D. L. Smith, D. R. Hinton, P. S. Gill: Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood, 98, 1904-1913 (2001)
31. C. H. Heldin: Dimerization of cell surface receptors in signal transduction. Cell, 80, 213-223 (1995)
32. M. Marx, R. A. Perlmutter, J. A. Madri: Modulation of platelet-derived growth factor receptor expression in microvascular endothelial cells during in vitro angiogenesis. J Clin Invest, 93, 131-139 (1994) (Pubitemid 24030829)
33. R. F. Nicosia, S. V. Nicosia, M. Smith: Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol, 145, 1023-1029 (1994) (Pubitemid 24345649)
34. N. Tsutsumi, Y. Yonemitsu, Y. Shikada Y, M. Onimaru, M. Tanii, S. Okano, K. Kaneko, M. Hasegawa, M. Hashizume, Y. Maehara, K. Sueishi: Essential role of PDGFRalpha-p70S6K signaling in mesenc hymal cells during therapeutic and tumor angiogenesis in vivo: role of PDGFRalpha during angiogenesis. Circ Res, 94, 1186-1191 (2004)
35. Y. Shikada, Y. Yonemitsu, T. Koga, M. Onimaru, T. Nakano, S. Okano, S. Sata, K. Nakagawa, I. Yoshino, Y. Maehara, K. Sueishi. Platelet-derived growth factor-AA is an essential and autocrine regulator of vascular endothelial growth factor expression in non-small cell lung carcinomas. Cancer Res, 65, 7241-7248 (2005) (Pubitemid 41161255)
36. S. Dias, M. Choy, K. Alitalo, S. Rafii: Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, surv ival, and resistance to chemotherapy. Blood, 99, 2179-2184 (2002) (Pubitemid 34525504)
37. J. L. Su, P. C. Yang, J. Y. Shih, C. Y. Yang, L. H. Wei, C. Y. Hsieh, C. H. Chou, Y. M. Jeng, M. Y. Wang, K. J. Chang, M. C. Hung, M. L. Kuo: The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell, 9, 209-223 (2006)
38. K. Jennbacken, C. Vallbo, W. Wang, J. E. Damber. Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis. Prostate , 65, 110-116 (2005) (Pubitemid 41362277)
39. Y. Yokoyama, D. S. Charnock-Jones, D. Licence, A. Yanaihara, J. M. Hastings, C. M. Holland, M. Emoto, A. Sakamoto, T. Sakamoto, H. Maruyama, S. Sato, H. Mizunuma, S. K. Smith: Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma. Clin Cancer Res, 9, 1361-1369 (2003) (Pubitemid 36418387)
40. P. Lindahl, B. R. Johansson, P. Leveen, C. Betsholtz. Pericyte loss and microaneurysm formation in PDGF-Bdeficient mice. Science, 277, 242-245 (1997) (Pubitemid 27446080)
41. M. F. McCarty, R. J. Somcio, O. Stoeltzing, J. Wey, F. Fan, W. Liu, C. Bucana, L. M. Ellis: Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content. J Clin Invest, 117, 2114-2122 (2007) (Pubitemid 47219556)
42. M. Onimaru, Y. Yonemitsu, H Suzuki, T. Fujii, K. Sueishi: An autocrine linkage between matrix metalloproteinase-14 and Tie-2 via ectodomain shedding modulates angiopoietin-1-dependent function in endot helial cells. Arterioscler Thromb Vasc Biol, 30, 818-826 (2010)
43. G. T. Stavri, I. C. Zachary, P. A. Baskerville, J. F. Martin, J. D. Erusalimsky: Basic fibroblast growth factor upre gulates the expression of vascular endothelial growth factor in vascular smooth muscle cells: synergistic interaction with hypoxia. Circulation, 92, 11-14 (1995)
44. T. Fujii, Y. Yonemitsu, M. Onimaru, M. Tanii, T. Nakano, K. Egashira, T. Takehara, M. Inoue, M. Hasegawa, H. Kuwano, K. Sueishi: Nonendothelial mesenchymal cellderived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of th e inflammatory/arteriogenic pathway. Arterioscler Thromb Vasc Biol, 26, 2483-2489 (2006) (Pubitemid 44607469)
45. M. Guba, P. von Breitenbuch, M. Steinbauer, G. Koehl, S. Flegel, M. Hornung, C. J. Bruns, C. Zuelke, S. Farkas, M. Anthuber, K. W. Jauch, E. K. Geissler: Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med, 8, 128-135 (200 2) (Pubitemid 34155123)
46. H. Seeliger, M. Guba, A. Kleespies, K. W. Jauch, C. J. Bruns: Role of mTOR in solid tumor systems: a therapeutical target against primary tumor growth, metastases, and angiogenesis. Cancer Metastasis R ev, 26, 611-621 (2007) (Pubitemid 350115107)
47. R. K. Jain: Normalizing tumor vasculature with antiangiogenic therapy: a new paradigm for combination therapy. Nat Med, 7, 987-989 (2001) (Pubitemid 32937367)
48. R. K. Jain: Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science, 307, 58-62 (2005) (Pubitemid 40093472)
49. R. Morishita, M. Aoki, N. Hashiya, K. Yamasaki, H. Kurinami, S. Shimizu, H. Makino, Y. Takesya, J. Azuma, T. Ogihara: Therapeutic angiogenesis using hepatocyte growth factor (HGF). Curr Gene Ther, 4, 199-206 (2004) (Pubitemid 38842622)
50. E. T. Shinohara, A. Maity: Increasing sensitivity to radiotherapy and chemotherapy by using novel biological agents that alter the tumor microenvironment. Curr Mol Med, 9, 1034-1045 (2009)
51. J. Hamzah, M. Jugold, F. Kiessling, P. Rigby, M. Manzur, H. H. Marti, T. Rabie, S. Kaden, H. J. Gröne, G. J. Hämmerling, B. Arnold, R. Ganss: Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature, 15, 410-414 (2008) (Pubitemid 351693122)